New life science company LQT Therapeutics grabs seed funding
Laval, Quebec's LQT Therapeutics, a new life science company focused on treating Long QT Syndrome, has raised C$1.8 million in a seed-stage financing.
Laval, Quebec's LQT Therapeutics, a new life science company focused on treating Long QT Syndrome, has raised C$1.8 million in a seed-stage financing.
Copyright PEI Media
Not for publication, email or dissemination